相关实验视频
Updated: May 10, 2025

06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.2K
了解和准急性髓性白血病中的代谢脆弱性:最新的综合性审查
Sridevi Addanki1, Lana Kim1, Alexandra Stevens1
1Division of Pediatric Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Cancers
|April 26, 2025
概括
急性髓性白血病 (AML) 细胞为生存重编程新陈代谢,提供独特的治疗点. 针对这些代谢漏洞,如改变线粒体功能和生物合成,显示出有效的AML治疗的希望.
科学领域:
- 生物化学 生物化学
- 癌症生物学 癌症生物学
- 血液学 血液学 血液学
背景情况:
- 急性髓性白血病 (AML) 呈现出积极的增殖和代谢重编程.
- 与正常的造血干细胞 (HSC) 相比,AML细胞表现出改变的线粒体功能,氧化酸化 (OXPHOS) 和生物合成途径.
研究的目的:
- 审查AML细胞和正常HSC之间的代谢区别.
- 突出 AML 细胞中的代谢脆弱性作为潜在的治疗点.
主要方法:
- 关于AML细胞代谢的当前文献的审查.
- 对白血病进展和治疗抵抗中的代谢重编程的分析.
主要成果:
- AML细胞显示线粒体生物发生的增加,依赖糖解和氨基酸代谢.
- 代谢依赖维持白血病干细胞 (LSCs),并有助于治疗耐药性.
- 代谢抑制剂在破坏AML细胞存活的过程中表现出有效性,同时保护正常细胞.
结论:
- 针对AML的代谢脆弱性提供了一个有前途的治疗策略.
- 代谢疗法,包括糖解,氨基酸和脂质代谢的抑制剂,显示出克服药物耐药性的潜力.
- 对代谢可塑性和精密医学的进一步研究对于改善AML治疗结果至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K

